Quantbot Technologies’s Allogene Therapeutics ALLO Stock Holding History

Quantbot Technologies’s Portfolio ALLO Stock Details ALLO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$243K	Buy	116,933 +116,067	+13,403%	+$255K	0.01%	1203
2026 Q1	$2.11K	Buy	+866	New	+$1.74K	﹤0.01%	1607
2024 Q1	–	Sell	-45,900	Closed	-$147K	–	1518
2023 Q4	$147K	Buy	45,900 +41,800	+1,020%	+$119K	0.01%	1088
2023 Q3	$13K	Buy	+4,100	New	+$18K	﹤0.01%	1385
2023 Q2	–	Sell	-3,400	Closed	-$16.8K	–	1538
2023 Q1	$16.8K	Buy	+3,400	New	+$21.8K	﹤0.01%	1366
2022 Q4	–	Sell	-13,700	Closed	-$147K	–	1636
2022 Q3	$147K	Buy	+13,700	New	+$186K	0.01%	986
2022 Q2	–	Sell	-34,607	Closed	-$315K	–	1667
2022 Q1	$315K	Sell	34,607 -500	-1%	-$5.21K	0.03%	731
2021 Q4	$523K	Buy	+35,107	New	+$619K	0.04%	522
2021 Q3	–	Sell	-5,200	Closed	-$135K	–	1484
2021 Q2	$135K	Buy	+5,200	New	+$148K	0.01%	848
2021 Q1	–	Sell	-118	Closed	-$2K	–	1370
2020 Q4	$2K	Buy	+118	New	+$3.85K	﹤0.01%	1198
2020 Q3	–	Sell	-200	Closed	-$8K	–	1269
2020 Q2	$8K	Buy	+200	New	+$7.23K	﹤0.01%	947
2020 Q1	–	Sell	-1,400	Closed	-$36K	–	876
2019 Q4	$36K	Buy	+1,400	New	+$38.6K	﹤0.01%	993
2019 Q3	–	Sell	-3,600	Closed	-$96K	–	1245
2019 Q2	$96K	Buy	+3,600	New	+$100K	0.01%	765

Other funds holding ALLO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Pfizer New York $170M AUM 191.09% 1-Year Est. Return

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return

SCM

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Quantbot Technologies's ALLO Position: Q2 2026 in Review

Quantbot Technologies increased its Allogene Therapeutics (ALLO) stake by 13,403% in Q2 2026, buying an estimated $255K and bringing the position to 116,933 shares worth $243K. The position accounts for 0.01% of the portfolio, ranked #1203.

Quantbot Technologies first reported a position in ALLO in Q2 2019 and has held it in 13 quarters since. The position peaked at $523K in Q4 2021. 210 funds tracked by Wall St. Rank hold ALLO as of Q2 2026.

Quantbot Technologies held 116,933 shares of Allogene Therapeutics worth $243K as of Q2 2026.
Quantbot Technologies bought 116,067 Allogene Therapeutics shares in Q2 2026, an estimated $255K.
Allogene Therapeutics made up 0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1203 holding.
Quantbot Technologies first reported a position in Allogene Therapeutics in Q2 2019 and has held it in 13 quarters since.
Quantbot Technologies's Allogene Therapeutics position peaked at $523K in Q4 2021.
210 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.